Zbigniew Tański

615 total citations
14 papers, 482 citations indexed

About

Zbigniew Tański is a scholar working on Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Zbigniew Tański has authored 14 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Zbigniew Tański's work include RNA modifications and cancer (5 papers), Renal and related cancers (4 papers) and RNA Research and Splicing (4 papers). Zbigniew Tański is often cited by papers focused on RNA modifications and cancer (5 papers), Renal and related cancers (4 papers) and RNA Research and Splicing (4 papers). Zbigniew Tański collaborates with scholars based in Poland, Germany and Nepal. Zbigniew Tański's co-authors include Agnieszka Piekiełko‐Witkowska, Joanna Bogusławska, Piotr Popławski, Beata Rybicka, Hanna Kędzierska, Alicja Nauman, Monika Puzianowska‐Kuźnicka, Janusz Nauman, Adam Master and Sheue-yann Cheng and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and The Journal of Urology.

In The Last Decade

Zbigniew Tański

14 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zbigniew Tański Poland	12	320	156	118	79	70	14	482
Xiaomai Zhou China	4	353 1.1×	110 0.7×	160 1.4×	38 0.5×	117 1.7×	7	469
Beata Rybicka Poland	12	286 0.9×	170 1.1×	35 0.3×	70 0.9×	59 0.8×	17	397
J E Nutt United Kingdom	11	141 0.4×	138 0.9×	59 0.5×	94 1.2×	160 2.3×	15	406
Stephen Hillerman United States	4	241 0.8×	105 0.7×	132 1.1×	80 1.0×	118 1.7×	5	427
Michał Świerniak Poland	12	393 1.2×	315 2.0×	197 1.7×	65 0.8×	69 1.0×	19	627
Dianqi Xin China	13	421 1.3×	205 1.3×	41 0.3×	108 1.4×	157 2.2×	35	560
Fiona E. M. Gibbs United Kingdom	6	363 1.1×	172 1.1×	34 0.3×	40 0.5×	51 0.7×	7	417
Yun Mu China	11	296 0.9×	166 1.1×	42 0.4×	35 0.4×	41 0.6×	16	414
Emma Jernberg Sweden	10	157 0.5×	114 0.7×	54 0.5×	250 3.2×	111 1.6×	12	381
Hanna Kędzierska Poland	10	386 1.2×	207 1.3×	23 0.2×	70 0.9×	58 0.8×	13	492

Countries citing papers authored by Zbigniew Tański

Since Specialization

Citations

This map shows the geographic impact of Zbigniew Tański's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zbigniew Tański with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zbigniew Tański more than expected).

Fields of papers citing papers by Zbigniew Tański

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zbigniew Tański. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zbigniew Tański. The network helps show where Zbigniew Tański may publish in the future.

Co-authorship network of co-authors of Zbigniew Tański

This figure shows the co-authorship network connecting the top 25 collaborators of Zbigniew Tański. A scholar is included among the top collaborators of Zbigniew Tański based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zbigniew Tański. Zbigniew Tański is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Bogusławska, Joanna, Piotr Popławski, Saleh Alseekh, et al.. (2019). MicroRNA-Mediated Metabolic Reprograming in Renal Cancer. Cancers. 11(12). 1825–1825. 28 indexed citations

Kędzierska, Hanna, et al.. (2018). microRNA-mediated regulation of splicing factors SRSF1, SRSF2 and hnRNP A1 in context of their alternatively spliced 3′UTRs. Experimental Cell Research. 363(2). 208–217. 26 indexed citations

Bogusławska, Joanna, Piotr Popławski, Hanna Kędzierska, et al.. (2017). TGF-β1 targets a microRNA network that regulates cellular adhesion and migration in renal cancer. Cancer Letters. 412. 155–169. 44 indexed citations

Popławski, Piotr, Takayuki Tohge, Joanna Bogusławska, et al.. (2016). Integrated transcriptomic and metabolomic analysis shows that disturbances in metabolism of tumor cells contribute to poor survival of RCC patients. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(3). 744–752. 20 indexed citations

Kędzierska, Hanna, Piotr Popławski, Grażyna Hoser, et al.. (2016). Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer. International Journal of Molecular Sciences. 17(10). 1598–1598. 37 indexed citations

Bogusławska, Joanna, Hanna Kędzierska, Piotr Popławski, et al.. (2015). Expression of Genes Involved in Cellular Adhesion and Extracellular Matrix Remodeling Correlates with Poor Survival of Patients with Renal Cancer. The Journal of Urology. 195(6). 1892–1902. 98 indexed citations

Master, Adam, Anna Wójcicka, Agnieszka Piekiełko‐Witkowska, et al.. (2010). Untranslated regions of thyroid hormone receptor beta 1 mRNA are impaired in human clear cell renal cell carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(11). 995–1005. 33 indexed citations

Piekiełko‐Witkowska, Agnieszka, Anna Wójcicka, Piotr Popławski, et al.. (2010). Disturbed Expression of Splicing Factors in Renal Cancer Affects Alternative Splicing of Apoptosis Regulators, Oncogenes, and Tumor Suppressors. PLoS ONE. 5(10). e13690–e13690. 43 indexed citations

Piekiełko‐Witkowska, Agnieszka, Adam Master, Anna Wójcicka, et al.. (2009). Disturbed Expression of Type 1 Iodothyronine Deiodinase Splice Variants in Human Renal Cancer. Thyroid. 19(10). 1105–1113. 19 indexed citations

10.

Turowska, Olga, Alicja Nauman, Maciej Pietrzak, et al.. (2007). Overexpression of E2F1 in Clear Cell Renal Cell Carcinoma: A Potential Impact of Erroneous Regulation by Thyroid Hormone Nuclear Receptors. Thyroid. 17(11). 1039–1048. 10 indexed citations

11.

Nauman, Alicja, Olga Turowska, Piotr Popławski, et al.. (2007). Elevated cyclin E level in human clear cell renal cell carcinoma: possible causes and consequences.. Acta Biochimica Polonica. 54(3). 595–602. 17 indexed citations

12.

Puzianowska‐Kuźnicka, Monika, et al.. (2003). Vitamin D Receptor Binding to DNA Is Altered without the Change in Its Expression in Human Renal Clear Cell Cancer. Nephron Experimental Nephrology. 93(4). e150–e157. 9 indexed citations

13.

Pachucki, Janusz, et al.. (2001). Type I 5′-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma. Journal of Endocrinological Investigation. 24(4). 253–261. 41 indexed citations

14.

Puzianowska‐Kuźnicka, Monika, et al.. (2000). Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma. Cancer Letters. 155(2). 145–152. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact